| Issue Type | Login |
|---|---|
| Country | Japan |
| Industry | Login |
| Region | Login |
| Maturity Date | 2026-08-31 |
| Par Value | 100000000 |
| Callable | Login |
| Next Call Date | Login |
| Call Type | Login |
| Call Price (%) | Login |
| Series | Login |
| Class | Login |
| Maturity Structure | Login |
| Amount Outstanding (mil) | 100000.00 |
| Coupon | 0.32 |
|---|---|
| Coupon Type | Login |
| Coupon Frequency | Login |
| First Coupon Date | Login |
| Last Coupon Date | Login |
| Sinking Fund | Login |
|---|---|
| Security | Login |
| Subordination | Login |
| Debt Type | Login |
| Issue Date | Login |
|---|---|
| Dated Date | Login |
| Issue Size (mil) | 100000 |
| Min. Piece | Login |
| Min. Increment | Login |
This Astellas Pharma Inc. corporate bond has a 0.32% fixed rate coupon paid on a Login basis. It was issued on MAR 12, 2000 with an issue size of 100000.00 million JPY and matures on August 31, 2026 with a last coupon date of FEB 28, 2020. |
Astellas Pharma Inc., founded in 2005 and headquartered in Tokyo, Japan, is a leading global pharmaceutical company dedicated to improving the health of patients through innovative medicines. The company specializes in a range of therapeutic areas, including urology, oncology, immunology, and neuroscience, with key products such as Xtandi, a treatment for prostate cancer, and Betanis for overactive bladder.